These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31788994)

  • 41. Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand.
    Ruanpeng D; Chariyalertsak S; Kaewpoowat Q; Supindham T; Settakorn J; Sukpan K; Utaipat U; Miura T; Kosashunhanan N; Saokhieo P; Songsupa R; Wongthanee A
    PLoS One; 2016; 11(5):e0156280. PubMed ID: 27227684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.
    Combita AL; Reyes V; Puerto D; Murillo R; Sánchez R; Nuñez M; Hernandez-Suarez GA; Wiesner C
    Cancer Prev Res (Phila); 2022 Jan; 15(1):55-66. PubMed ID: 34610993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
    Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing Cervical Cytology and Histology Among Human Papillomavirus-Vaccinated and -Unvaccinated Women in an Academic Colposcopy Clinic.
    Dorton BJ; Vitonis AF; Feldman S
    Obstet Gynecol; 2015 Oct; 126(4):785-791. PubMed ID: 26348184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Differential Risk of Cervical Cancer in HPV-Vaccinated and -Unvaccinated Women: A Mathematical Modeling Study.
    Naslazi E; Hontelez JAC; Naber SK; van Ballegooijen M; de Kok IMCM
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):912-919. PubMed ID: 33837119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical cancer screening varies by HPV vaccination status among a National Cohort of privately insured young women in the United States 2006-2016.
    Ba DM; McCall-Hosenfeld JS; Ssentongo P; Chinchilli VM; Agbese E; Liu G; Leslie DL; Du P
    Medicine (Baltimore); 2021 Oct; 100(41):e27457. PubMed ID: 34731120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination.
    Batmunkh T; Dalmau MT; Munkhsaikhan ME; Khorolsuren T; Namjil N; Surenjav U; Toh ZQ; Licciardi PV; Russell FM; Garland SM; Mulholland K; von Mollendorf C
    Vaccine; 2020 Jun; 38(27):4316-4324. PubMed ID: 32387009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
    Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA
    Vaccine; 2021 Aug; 39(34):4856-4863. PubMed ID: 34281743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    Yoon D; Lee JH; Lee H; Shin JY
    BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus genotype distribution by cytological status and associated risk factors in the general population of Congolese women living in urban and rural areas: Implications for cervical cancer prevention.
    Tsimba Lemba PC; Boumba LMA; Péré H; Nganga PC; Veyer D; Puech J; Mboumba Bouassa RS; Malanda-Kiminou P; Moukassa D; Bélec L
    Infect Dis Now; 2023 Oct; 53(8):104762. PubMed ID: 37454761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
    Khoo SP; Muhammad Ridzuan Tan NA; Rajasuriar R; Nasir NH; Gravitt P; Ng CW; Woo YL
    PLoS One; 2022; 17(12):e0278477. PubMed ID: 36538522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study.
    Saldanha C; Vieira-Baptista P; Costa M; Silva AR; Picão M; Sousa C
    J Low Genit Tract Dis; 2020 Oct; 24(4):363-366. PubMed ID: 32796265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical Screening in North Sardinia (Italy): Genotype Distribution and Prevalence of HPV among Women with ASC-US Cytology.
    Muresu N; Sotgiu G; Marras S; Gentili D; Sechi I; Cossu A; Dettori A; Pietri RE; Paoni L; Ghi ME; Bagella MP; Marrazzu A; Cossu A; Genovesi A; Piana A; Saderi L
    Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    Sarmiento-Medina MI; de Amaya MP; Villamizar-Gómez L; González-Coba AC; Guzmán-Barajas L
    PLoS One; 2024; 19(2):e0297579. PubMed ID: 38315664
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012-2018: baseline measures prior to mass HPV vaccination.
    Luo LP; He P; Liu QT; Jiang YH; Zhang YN; Li QZ; Li Q; Li ST; Yang F; Ling H; Dai XG; Li ZY; Chen HL
    BMC Infect Dis; 2021 Apr; 21(1):328. PubMed ID: 33827456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia.
    Seyoum A; Seyoum B; Gure T; Alemu A; Alemayehu DH; Alemu A; Belachew A; Tefera DA; Aseffa A; Howe R; Mulu A; Mihret A
    Sci Rep; 2024 Jan; 14(1):958. PubMed ID: 38200092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.